Neutralizing monoclonal antibodies against ricin's enzymatic subunit interfere with protein disulfide isomerase-mediated reduction of ricin holotoxin in vitro

Journal of Immunological Methods

Volumn 395, Issue 1-2, 2013, Pages 71-78

  O'Hara, Joanne M ^a,b   Mantis, Nicholas J ^a,b  

^a WADSWORTH CENTER   (United States)

^b UNIVERSITY AT ALBANY   (United States)

Author keywords

Antibody; Intracellular; Neutralization; Toxin

Indexed keywords

IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY GD12; MONOCLONAL ANTIBODY R70; MONOCLONAL ANTIBODY SYH7; NEUTRALIZING ANTIBODY; PROTEIN DISULFIDE ISOMERASE; RICIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BINDING KINETICS; CARBOXY TERMINAL SEQUENCE; CELL ADHESION; CELL SURFACE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DISULFIDE BOND; ENDOPLASMIC RETICULUM; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SUBUNIT; FEMALE; HOST CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RICINUS COMMUNIS; SPLEEN CELL; VERO CELL; WESTERN BLOTTING;

ANTIBODY; INTRACELLULAR; NEUTRALIZATION; TOXIN;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIBODY SPECIFICITY; CELL LINE; CERCOPITHECUS AETHIOPS; HUMANS; IMMUNOGLOBULIN G; MICE; MICROSCOPY, CONFOCAL; MODELS, MOLECULAR; OXIDATION-REDUCTION; PROTEIN DISULFIDE-ISOMERASES; PROTEIN SUBUNITS; RICIN; TOXINS, BIOLOGICAL; VERO CELLS;

MAMMALIA;

EID: 84881552466     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2013.06.004     Document Type: Article

References (36)

1. Baillie L.W., Huwar T.B., Moore S., Mellado-Sanchez G., Rodriguez L., Neeson B.N., Flick-Smith H.C., Jenner D.C., Atkins H.S., Ingram R.J., Altmann D.M., Nataro J.P., Pasetti M.F. An anthrax subunit vaccine candidate based on protective regions of Bacillus anthracis protective antigen and lethal factor. Vaccine 2010, 28:6740.
2. Bellisola G., Fracasso G., Ippoliti R., Menestrina G., Rosen A., Solda S., Udali S., Tomazzolli R., Tridente G., Colombatti M. Reductive activation of ricin and ricin A-chain immunotoxins by protein disulfide isomerase and thioredoxin reductase. Biochem. Pharmacol. 2004, 67:1721.
3. Carra J.H., Wannemacher R.W., Tammariello R.F., Lindsey C.Y., Dinterman R.E., Schokman R.D., Smith L.A. Improved formulation of a recombinant ricin A-chain vaccine increases its stability and effective antigenicity. Vaccine 2007, 25:4149.
4. Colombatti M., Pezzini A., Colombatti A. Monoclonal antibodies against ricin: effects on toxin function. Hybridoma 1986, 5:9.
5. Endo Y., Mitsui K., Motizuki M., Tsurugi K. The mechanism of action of ricin and related toxins on eukaryotic ribosomes. J. Biol. Chem. 1987, 262:5908.
6. Ganesan R., Eigenbrot C., Kirchhofer D. Structural and mechanistic insight into how antibodies inhibit serine proteases. Biochem. J. 2010, 430:179.
7. Hatahet F., Ruddock L.W. Substrate recognition by the protein disulfide isomerases. FEBS J. 2007, 274:5223.
8. Holmgren A. Enzymatic reduction-oxidation of protein disulfides by thioredoxin. Methods Enzymol. 1984, 107:295.
9. Lemley P.V., Amanatides P., Wright D.C. Identification and characterization of a monoclonal antibody that neutralizes ricin toxicity in vitro and in vivo. Hybridoma 1994, 13:417.
10. Lord J.M., Spooner R.A. Ricin trafficking in plant and mammalian cells. Toxins (Basel) 2011, 3:787.
11. Maddaloni M., Cooke C., Wilkinson R., Stout A.V., Eng L., Pincus S.H. Immunological characteristics associated with the protective efficacy of antibodies to ricin. J. Immunol. 2004, 172:6221.
12. McKee M.L., FitzGerald D.J. Reduction of furin-nicked Pseudomonas exotoxin A: an unfolding story. Biochemistry 1999, 38:16507.
13. Meagher M.M., Seravalli J.G., Swanson S.T., Ladd R.G., Khasa Y.P., Inan M., Harner J.C., Johnson S.K., Van Cott K., Lindsey C., Wannemacher R., Smith L.A. Process development and cGMP manufacturing of a recombinant ricin vaccine: an effective and stable recombinant ricin a-chain vaccine-RVEc. Biotechnol. Prog. 2011, 27:1036-1047.
14. Neal L.M., O'Hara J., Brey R.N., Mantis N.J. A monoclonal immunoglobulin G antibody directed against an immunodominant linear epitope on the ricin A chain confers systemic and mucosal immunity to ricin. Infect. Immun. 2010, 78:552.
15. O'Hara J.M., Neal L.M., McCarthy E.A., Kasten-Jolly J.A., Brey R.N., Mantis N.J. Folding domains within the ricin toxin A subunit as targets of protective antibodies. Vaccine 2010, 28:7035.
16. O'Hara J.M., Yermakova A., Mantis N.J. Immunity to ricin: fundamental insights into toxin-antibody interactions. Curr. Top. Microbiol. Immunol. 2012, 357:209.
17. O'Hara J.M., Brey R.N., Mantis N.J. Comparative efficacy in mice of two lead candidate ricin toxin a subunit (RTA) vaccine. Clin. Vaccine Immunol. 2013, 287:7367-7373.
18. Pasetto M., Barison E., Castagna M., Della Cristina P., Anselmi C., Colombatti M. Reductive activation of type 2 ribosome inactivating proteins (RIPs 2) is promoted by transmembrane thioredoxin-related protein (TMX). J. Biol. Chem. 2012.
19. Prigent J., Panigai L., Lamourette P., Sauvaire D., Devilliers K., Plaisance M., Volland H., Creminon C., Simon S. Neutralising antibodies against ricin toxin. PLoS One 2011, 6:e20166.
20. Rapak A., Falnes P.O., Olsnes S. Retrograde transport of mutant ricin to the endoplasmic reticulum with subsequent translocation to cytosol. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:3783.
21. Reisler R.B., Smith L.A. The need for continued development of ricin countermeasures. Adv. Prev. Med. 2012, 2012:149737.
22. Reynolds K.A., McLaughlin R.N., Ranganathan R. Hot spots for allosteric regulation on protein surfaces. Cell 2011, 147:1564.
23. Rutenber E., Ready M., Robertus J.D. Structure and evolution of ricin B chain. Nature 1987, 326:624.
24. Rutenber E., Katzin B.J., Ernst S., Collins E.J., Mlsna D., Ready M.P., Robertus J.D. Crystallographic refinement of ricin to 2.5 A. Proteins 1991, 10:240.
25. Sandvig K., Grimmer S., Lauvrak S.U., Torgersen M.L., Skretting G., van Deurs B., Iversen T.G. Pathways followed by ricin and Shiga toxin into cells. Histochem. Cell Biol. 2002, 117:131.
26. Sela-Culang I., Alon S., Ofran Y. A systematic comparison of free and bound antibodies reveals binding-related conformational changes. J. Immunol. 2012, 189:4890-4899.
27. Spooner R.A., Lord J.M. How ricin and Shiga toxin reach the cytosol of target cells: retrotranslocation from the endoplasmic reticulum. Curr. Top. Microbiol. Immunol. 2012, 357:19.
28. Spooner R.A., Watson P.D., Marsden C.J., Smith D.C., Moore K.A., Cook J.P., Lord J.M., Roberts L.M. Protein disulphide-isomerase reduces ricin to its A and B chains in the endoplasmic reticulum. Biochem. J. 2004, 383:285.
29. Tsai B., Rodighiero C., Lencer W.I., Rapoport T.A. Protein disulfide isomerase acts as a redox-dependent chaperone to unfold cholera toxin. Cell 2001, 104:937.
30. van Deurs B., Tonnessen T.I., Petersen O.W., Sandvig K., Olsnes S. Routing of internalized ricin and ricin conjugates to the Golgi complex. J. Cell Biol. 1986, 102:37.
31. van Deurs B., Sandvig K., Petersen O.W., Olsnes S., Simons K., Griffiths G. Estimation of the amount of internalized ricin that reaches the trans-Golgi network. J. Cell Biol. 1988, 106:253.
32. Vitetta E.S., Smallshaw J.E., Schindler J. A small phase IB clinical trial of an alhydrogel-adsorbed recombinant ricin vaccine (RiVax). Clin. Vaccine Immunol. 2012, 19:1697-1699.
33. Walczak C.P., Bernardi K.M., Tsai B. Endoplasmic reticulum-dependent redox reactions control endoplasmic reticulum-associated degradation and pathogen entry. Antioxid. Redox Signal. 2012, 16:809.
34. Yermakova A., Mantis N.J. Protective immunity to ricin toxin conferred by antibodies against the toxin's binding subunit (RTB). Vaccine 2011, 29:7925.
35. Yermakova A., Mantis N.J. Neutralizing activity and protective immunity to ricin toxin conferred by B subunit (RTB)-specific Fab fragments. Toxicon 2013, (PMID: 23603317, in press). 10.1016/j.toxicon.2013.04.005.
36. Yermakova A., Vance D.J., Mantis N.J. Sub-domains of ricin's B subunit as targets of toxin neutralizing and non-neutralizing monoclonal antibodies. PLoS One 2012, 7:e44317.